Gossamer Bio Inc logo

Gossamer Bio Inc

$ 2.36 -6.93 (-74.6%) 10:08 PM EST
P/E:
At Loss
P/B:
3.93
Market Cap:
$ 222.97M
Enterprise V:
$ 802.37M
Volume:
56.46M
Avg Vol (2M):
1.58M
Also Trade In:
Volume:
56.46M
Market Cap $:
222.97M
PE Ratio:
At Loss
Avg Vol (2-Month):
1.58M
Enterprise Value $:
802.37M
PB Ratio:
3.93
GF Score:
Year:
Not Enough Data to Display
To
10Y: -%
Above Low: +NaN%
Below High: NaN%
Not Enough Data to Display
Alerts Website SEC Filings Stock Report
Dataset
Financial Download

Business Description

Description
Gossamer Bio Inc is a clinical-stage biopharmaceutical company. It focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology. The company pipeline products include Seralutinib, which address the cellular overgrowth, fibrosis, and vascular remodeling which underlie PAH (pulmonary arterial hypertension); GB004, for the treatment of inflammatory bowel disease, including ulcerative colitis and Crohn's disease; GB1275, for the treatment of oncology indications; and GB001, for the treatment of moderate-to-severe eosinophilic asthma.
Name Current Vs Industry Vs History
Cash-To-Debt 1.33
Equity-to-Asset 0.17
Debt-to-Equity 4.07
Debt-to-EBITDA -1.09
Piotroski F-Score 1/9
0
1
2
3
4
5
6
7
8
9
WACC vs ROIC
WACC
ROIC

Growth Rank

Name Current Vs Industry Vs History
3-Year EBITDA Growth Rate -4.8
3-Year EPS without NRI Growth Rate -8.8
3-Year FCF Growth Rate -28.6
Name Current Vs Industry Vs History
5-Day RSI 9.42
9-Day RSI 12.31
14-Day RSI 15.3
6-1 Month Momentum % 56.32
12-1 Month Momentum % 0.57

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 5.93
Quick Ratio 5.93
Cash Ratio 5.78

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -7.8

Financials (Next Earnings Date:2023-03-03 Est.)

GOSS's 30-Y Financials

Guru Trades

See Details
To
Not Enough Data to Display

Insider Trades

See Details
To
Not Enough Data to Display

Gurus Latest Trades with NAS:GOSS

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To
Not Enough Data to Display

Performance

Dividend
Log
To
Not Enough Data to Display

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

Not Enough Data to Display

Valuation Box

Year:
Not Enough Data to Display

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $)
EPS (TTM) ($) -2.89
Beta 0.89
Volatility % 62.65
14-Day RSI 15.3
14-Day ATR ($) 1.100262
20-Day SMA ($) 8.9355
12-1 Month Momentum % 0.57
52-Week Range ($) 2.15 - 15.195
Shares Outstanding (Mil) 94.48

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 1
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Gossamer Bio Inc Filings

Document Form Filing Date
No Filing Data

Gossamer Bio Inc Analysis

Share your research

Headlines

See More
No news.